# Glycopyrrolate

NDC: 65219-801
Generic name: Glycopyrrolate
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20231231

FDA application: ANDA209328

## Active ingredients

- GLYCOPYRROLATE: .2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65219-801"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65219-801
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=250eeef7-b1a9-45e7-a927-7807232e10be